The conversation around cannabis rescheduling in the United States is heating up, and for good reason. Investors are eager to know what moving cannabis from Schedule I to Schedule III could mean—not just for the broader legal cannabis industry, but especially for multi-state operators (MSOs) like LEEF Brands Inc. (CSE: LEEF) (OTCQB: LEEEF) and investment vehicles like AdvisorShares Pure US Cannabis ETF (MSOS). Let’s explore how this regulatory shift could play out and why it’s generating so much buzz among public company investors.
The Big Picture: Why Rescheduling Matters
If you’ve followed the cannabis sector, you know that federal law has long been a thorn in the side of legal operators. Right now, cannabis is classified as a Schedule I substance, putting it in the same category as heroin and making it nearly impossible for companies to operate like normal businesses. The most immediate pain point? Section 280E of the Internal Revenue Code. This rule prevents cannabis companies from deducting ordinary business expenses, leaving many with sky-high tax bills—sometimes as much as 60–70% of their profits vanish to the IRS.
Rescheduling cannabis to Schedule III would change this overnight. Suddenly, legal operators could deduct salaries, rent, marketing, and other standard expenses, just like any other business. For many companies, this would be a game-changer, turning marginal or negative cash flow into real profitability.
Beyond Taxes: Banking, Investment, and Compliance
But tax relief is just the beginning. While rescheduling wouldn’t instantly solve every banking headache, it would make the industry less risky in the eyes of traditional financial institutions. That means easier access to loans, basic banking services, and potentially even credit card processing—things most businesses take for granted, but which have been out of reach for many cannabis operators.
There’s also the question of regulatory clarity. Moving cannabis to Schedule III would likely mean a new set of compliance standards, possibly requiring state-licensed operators to register with the DEA and follow stricter record-keeping rules. For some, this might sound daunting, but it’s also a sign that the industry is maturing and gaining legitimacy in the eyes of regulators and investors alike.
It’s important to note, though, that interstate commerce wouldn’t be legalized by rescheduling alone. Cannabis would still need to be grown, processed, and sold within state lines—at least for now. But this move could lay the groundwork for future reforms that might open up national supply chains down the road.
What About Multi-State Operators Like LEEF Brands?
For MSOs, the potential benefits are even greater. These companies often have large, complex operations spanning several states, which means they’re hit hardest by the current tax regime. Removing the 280E burden could save millions in annual expenses, freeing up cash to reinvest in expansion, innovation, and talent.
Take LEEF Brands as a case in point. This vertically integrated operator has built a strong presence in California and recently made a strategic move into New York, acquiring a coveted Type 1 Cannabis Processor License. With expertise in extraction and concentrates, LEEF is well-positioned to capture a share of New York’s rapidly growing market—projected to hit $1.5 billion in retail sales next year.
For LEEF, the ability to deduct ordinary business expenses could be transformative. Improved cash flow would help the company accelerate its growth plans, invest in new markets, and weather the ups and downs of a still-evolving industry. The company has posted positive EBITDA for three straight quarters and has enacted several measures to increase profitability. The rescheduling of its products could significantly boost those efforts.
See LEEF Brands’ CEO Micah Anderson discuss how the extraction company’s move to cultivate one of the world’s largest cannabis farms will improve operations, quality assurance, and the bottom line.
LEEF’s move into the MSO world is fairly recent, and the market is still in the discovery phase of what the company’s true value might be. Its wholly-owned Salisbury Canyon Ranch, home to what will be perhaps the world’s largest cannabis farms when all 187 licensable acres are planted, was appraised for $40 million. That asset alone is about 30% higher than its current market cap of $30 million.
What Should Investors Watch For?
Investors interested in the potential for US MSOs should also be tracking the AvisorShares ETF (MSOS) that consists of more established American operators. The fund has traded up about 50% in the last few weeks as conservative commenters on social media seem to be taking up the cause and hinting at President Trump’s support for the rescheduling of the drug.
All told, cannabis rescheduling could be the catalyst that finally brings the legal industry into the financial mainstream. Tax relief, better access to banking, and a more predictable regulatory framework would make the sector more attractive to institutional investors and public markets alike. For MSOs like LEEF Brands, it’s an opportunity to scale up, strengthen their brands, and deliver real value to shareholders.
Of course, there are still hurdles ahead—new compliance requirements, ongoing state-by-state restrictions, and the ever-present risk of political shifts. But for investors willing to navigate these complexities, the potential rewards are growing clearer by the day. Rescheduling may not be a silver bullet, but it marks a pivotal step toward a more stable, profitable, and investable cannabis industry.
